Regulation of miR-181a expression in T cell aging

被引:0
作者
Zhongde Ye
Guangjin Li
Chulwoo Kim
Bin Hu
Rohit R. Jadhav
Cornelia M. Weyand
Jörg J. Goronzy
机构
[1] Stanford University,From the Department of Medicine, Division of Immunology and Rheumatology
[2] Veterans Affairs Palo Alto Health Care System,Department of Medicine
来源
Nature Communications | / 9卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
MicroRNAs have emerged as key regulators in T cell development, activation, and differentiation, with miR-181a having a prominent function. By targeting several signaling pathways, miR-181a is an important rheostat controlling T cell receptor (TCR) activation thresholds in thymic selection as well as peripheral T cell responses. A decline in miR-181a expression, due to reduced transcription of pri-miR-181a, accounts for T cell activation defects that occur with older age. Here we examine the transcriptional regulation of miR-181a expression and find a putative pri-miR-181a enhancer around position 198,904,300 on chromosome 1, which is regulated by a transcription factor complex including YY1. The decline in miR-181a expression correlates with reduced transcription of YY1 in older individuals. Partial silencing of YY1 in T cells from young individuals reproduces the signaling defects seen in older T cells. In conclusion, YY1 controls TCR signaling by upregulating miR-181a and dampening negative feedback loops mediated by miR-181a targets.
引用
收藏
相关论文
共 128 条
[1]  
Boraschi D(2013)The gracefully aging immune system Sci. Transl. Med 5 185-188
[2]  
Nikolich-Zugich J(2018)The twilight of immunity: emerging concepts in aging of the immune system Nat. Immunol. 19 10-19
[3]  
Morrisette-Thomas V(2014)Inflamm-aging does not simply reflect increases in pro-inflammatory markers Mech. Ageing Dev. 139 49-57
[4]  
Howcroft TK(2013)The role of inflammation in age-related disease Aging 5 84-93
[5]  
Peters MJ(2015)The transcriptional landscape of age in human peripheral blood Nat. Commun. 6 179-186
[6]  
Thompson WW(2003)Mortality associated with influenza and respiratory syncytial virus in the United States JAMA 289 494-500
[7]  
Levin MJ(2012)Immune senescence and vaccines to prevent herpes zoster in older persons Curr. Opin. Immunol. 24 CD008858-1174
[8]  
Gagliardi AM(2012)Vaccines for preventing herpes zoster in older adults Cochrane Database Syst. Rev. 10 1165-1381
[9]  
Gomes Silva BN(2005)Efficacy and effectiveness of influenza vaccines in elderly people: a systematic review Lancet 366 1373-118
[10]  
Torloni MR(2007)Effectiveness of influenza vaccine in the community-dwelling elderly N. Engl. J. Med. 357 112-436